Cannabis Research
Cannabis Flavonoids and Chemotherapy: Glioblastoma Boost
Add MyCannabis.com to your preferred sources on Google
Emerging research suggests that certain compounds in cannabis could help make chemotherapy drugs more effective. A review1 published in Biomolecules in December 2021 found that cannabis-derived flavonoids exhibit activity against glioblastoma cells and may serve as adjuvants — substances that enhance the effectiveness of conventional cancer therapies.
What Are Cannabis Flavonoids?
Flavonoids are a group of bioactive molecules found in many plants, including cannabis. They contribute to a plant’s pigmentation, with some compounds like anthocyanins giving purple cannabis strains their distinctive hue. Beyond their visual impact, flavonoids are known for their anti-inflammatory and antioxidant properties.
In cannabis, flavonoids occur alongside cannabinoids and terpenes, forming part of the plant’s complex chemical profile. Scientists are now studying their potential role in cancer treatment.
Understanding Glioblastoma
Glioblastoma (GBM) is an aggressive brain tumor that originates in astrocytes, the star-shaped cells in the central nervous system. Standard treatment typically involves a combination of surgery, radiation therapy, and chemotherapy. Despite these measures, glioblastoma remains difficult to treat, with high rates of recurrence and poor prognosis.
Key Findings from the Review
The review examined studies published between 2011 and 2021, assessing the interaction between cannabis flavonoids and standard chemotherapy drugs. The analysis found that flavonoids may enhance chemotherapy effectiveness by modulating multiple intracellular signaling pathways, including:
- Apoptosis (programmed cell death)
- Proliferation (cell growth and reproduction)
- Autophagy (cellular recycling and waste removal)
- Motility (cell movement)
- Chemoresistance (cancer cell resistance to drugs)
By influencing these pathways, flavonoids could work synergistically with chemotherapy drugs to slow tumor progression, improve drug response, and potentially reduce required dosages.
| Treatment Approach | Standard Chemotherapy | Chemotherapy + Cannabis Flavonoids |
|---|---|---|
| Primary Mechanism | Targets rapidly dividing tumor cells | Targets tumor cells + modulates cell signaling pathways |
| Apoptosis (Cell Death) | Induces apoptosis in cancer cells | May enhance apoptosis signaling, increasing cancer cell death |
| Cell Proliferation | Suppresses cell growth | May improve suppression of tumor growth rates |
| Autophagy | Limited influence on autophagy | May help regulate autophagy for tumor suppression |
| Chemoresistance | Resistance can develop over time | Potential to reduce chemoresistance via pathway modulation |
| Side Effects | Systemic toxicity, immune suppression | Research suggests possible protective antioxidant effects; more studies needed |
Potential and Next Steps
While the review reinforces the known antioxidant and anti-inflammatory effects of flavonoids, it also highlights their underexplored role in oncology. The authors recommend more preclinical and clinical studies to confirm their therapeutic potential and determine how best to integrate them into glioblastoma treatment plans.
If further research confirms these findings, flavonoid-based therapies could become a valuable complement to current chemotherapy regimens, offering new hope in the fight against one of the most challenging brain cancers.
Reference:
1. Radwan, M.M., ElSohly, M.A., El-Alfy, A.T. et al. (2021). Cannabis flavonoids as potential adjunctive agents for glioblastoma treatment: A review. Biomolecules, 11(12), 1934. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699565/
